Roivant Sciences ROIV
NASDAQ ROIV
$36.50 -0.48 (-1.30%)
At close: Sep 29, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Operating Leases (2021 - 2026)

Updated

Roivant Sciences (ROIV) recorded Operating Leases of $94.77 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5.0% from $90.29 million a year earlier but down 1.6% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Operating Leases (2021 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Roivant Sciences reported Operating Leases of $96.29 million, up 6.6% from FY2025.

  • Annual Operating Leases has a five-year compound annual growth rate of 9.1% (FY2021 to FY2026).
  • Across earlier fiscal years, Operating Leases came in at $90.33 million in FY2025 (+100.6%), $45.02 million in FY2024 (-15.8%), $53.48 million in FY2023 (-14.4%) and $62.47 million in FY2022 (+0.1%).
  • Quarterly Operating Leases has ranged from $43.19 million in fiscal Q2 2025 to $98.5 million in fiscal Q3 2026 over the past five years.
  • On a year-over-year basis, Operating Leases has increased for seven consecutive quarters, with growth averaging 50.9% over the last eight quarters.
  • Peak year-over-year performance for Operating Leases in the last five years was growth of 108.0% in fiscal Q2 2026, against a decline of 17.1% in fiscal Q2 2023 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at $96.29 million (Q4 2026), $98.5 million (Q3 2026) and $89.84 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Roivant Sciences 26.72 Bn 27.41 Bn 1.16 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.77 Mn
Mar 31, 2026 96.29 Mn
Dec 31, 2025 98.50 Mn
Sep 30, 2025 89.84 Mn
Jun 30, 2025 90.29 Mn
Mar 31, 2025 90.33 Mn
Dec 31, 2024 90.48 Mn
Sep 30, 2024 43.19 Mn
Jun 30, 2024 45.85 Mn
Mar 31, 2024 45.02 Mn
Dec 31, 2023 47.06 Mn
Sep 30, 2023 48.63 Mn
Jun 30, 2023 51.81 Mn
Mar 31, 2023 53.48 Mn
Dec 31, 2022 54.93 Mn
Sep 30, 2022 54.09 Mn
Jun 30, 2022 60.40 Mn
Mar 31, 2022 62.47 Mn
Dec 31, 2021 62.09 Mn
Sep 30, 2021 65.22 Mn
API Access

Roivant Sciences Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ROIV&period=max&api_key=YOUR_API_KEY